Home » Topics » Regulatory » Patents

Patents
RSS

Elastase inhibitors synthesized at Glaxo Wellcome, useful for chronic bronchitis

May 4, 1999

Potent and selective COX-2 inhibitors in the Glaxo Wellcome pipeline

May 4, 1999

Azolidinedione derivatives for improving insulin resistance

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Wide-spectrum receptor binding profile for new tetrahydro gamma-carbolines

May 3, 1999

Inhibitors of factor Xa recently disclosed by DuPont

May 3, 1999

Duphar's new CRF antagonists and their use for stress-related disorders

May 3, 1999

Anti-HBV agents in development at Australian research center

May 3, 1999

Merck KGaA designs new agent with good neuroleptic activity, low liability for side effects

May 3, 1999

Orally active fibrinogen antagonist developed by Merck

May 3, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...